Wednesday, 28 June 2017

UC San Diego in partnership with Janssen

16 June 2017 | News

As part of this multi-project collaboration, UC San Diego School of Medicine and Janssen will bring together complementary expertise across a broad range of scientific disciplines.

University of California San Diego School of Medicine has entered a five-year strategic partnership with Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, to discover meaningful treatments for metabolic diseases.

As part of this multi-project collaboration, UC San Diego School of Medicine and Janssen will bring together complementary expertise across a broad range of scientific disciplines in order to identify pathways and mechanisms driving disease progression, as well as clinically useful biomarkers, therapeutic targets and gastric bypass approaches with potential to improve treatments for obesity and related conditions, including type 2 diabetes, non-alcoholic steatohepatitis (NASH), chronic kidney disease (CKD) and metabolic liver disease.

In the first year of the partnership, nine projects will be initiated focusing on the development of animal and cell models of NASH and CKD, as well as the discovery of mechanisms invoked by bariatric surgery, disease-related biomarkers and novel therapeutic targets. While each project is being led by principal investigators, all projects will be integrated to build on new discoveries. Researchers will also evaluate biological samples obtained from patients with various diseases using UC San Diego's core capabilities in high-throughput metabolomics, microbiome research and bioinformatics. A joint steering committee between UC San Diego and Janssen will oversee the collaboration, including project monitoring and ongoing project selection.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Will Asia- Pacific healthcare IT market hit the double digit growth in the next five years?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls